Polianta Ltd Sells 17,100 Shares of Centene Corporation $CNC

Posted by George Bondi on Aug 9th, 2026

Polianta Ltd decreased its position in shares of Centene Corporation (NYSE:CNC – Free Report) by 38.0% in the 2nd quarter, HoldingsChannel reports. The fund owned 27,900 shares of the company’s stock after selling 17,100 shares during the period. Polianta Ltd’s holdings in Centene were worth $1,790,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. DV Equities LLC bought a new stake in Centene during the 4th quarter valued at $26,000. IFC & Insurance Marketing Inc. bought a new position in shares of Centene in the fourth quarter valued at $28,000. SBI Securities Co. Ltd. grew its holdings in shares of Centene by 118.4% during the fourth quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock valued at $31,000 after buying an additional 406 shares during the last quarter. Bayban bought a new stake in shares of Centene during the fourth quarter worth about $33,000. Finally, MV Capital Management Inc. bought a new stake in shares of Centene during the fourth quarter worth about $34,000. 93.63% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on CNC. Robert W. Baird raised their price target on shares of Centene from $46.00 to $66.00 and gave the company a “neutral” rating in a research report on Wednesday, July 29th. Wall Street Zen raised Centene from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 18th. Zacks Research upgraded Centene from a “hold” rating to a “strong-buy” rating in a report on Wednesday, July 29th. Barclays reaffirmed an “overweight” rating and set a $80.00 target price (up from $75.00) on shares of Centene in a research report on Wednesday, July 29th. Finally, UBS Group reissued a “neutral” rating and issued a $61.00 price target (up from $55.00) on shares of Centene in a research report on Friday, May 22nd. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $68.58.

Check Out Our Latest Research Report on CNC

Centene Price Performance

Shares of NYSE:CNC opened at $65.69 on Friday. The company has a market capitalization of $32.45 billion, a P/E ratio of -6.29, a price-to-earnings-growth ratio of 0.35 and a beta of 1.08. The company’s 50-day moving average is $64.48 and its 200 day moving average is $50.92. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.15 and a current ratio of 1.15. Centene Corporation has a fifty-two week low of $25.18 and a fifty-two week high of $69.36.

Centene (NYSE:CNC – Get Free Report) last posted its quarterly earnings data on Tuesday, July 28th. The company reported $2.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.09 by $1.42. The business had revenue of $53.58 billion during the quarter, compared to the consensus estimate of $47.64 billion. Centene had a negative net margin of 2.51% and a positive return on equity of 12.12%. The firm’s quarterly revenue was up 9.9% compared to the same quarter last year. During the same quarter last year, the company posted ($0.16) earnings per share. Centene has set its FY 2026 guidance at 4.800- EPS. On average, equities research analysts forecast that Centene Corporation will post 4.89 earnings per share for the current year.

Centene Company Profile

(Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.